NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/02/2026
Voltar para busca
Dado oficial do USPTO
E
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
25/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10
Data de depósito
09/06/2021
Data de registro
24/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/02/2026
Última transação
25/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
14/03/2023
Primeiro uso no comércio
14/03/2023
Código do desenho
3
Tipo de titular
03
Localização do titular
San Diego, CA, US
Examinador
LE, KHANH M
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a stylized letter "E" inside of a square shape with one rounded corner.
Titulares e representantes
Titulares
Element Biosciences, Inc.
Representantes
Samantha C. Markley LOZA & LOZA, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for scientific research usefor diagnostic scientific usefor clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical diagnostic laboratory purposes
Classe 5
Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomoleculescomprised primarily of oligonucleotides and other nucleic acidsnatural and modified nucleotidespolypeptidesbufferslabelssubstratesfor clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acidsnaturally occurring or modified nucleotidesenzymeslabelsbuffersall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationtranscriptionexpression for diagnostic medical use and for clinical medical use
Classe 9
Computer systemscomputer hardwaredownloadable and recorded computer software and associated downloadable data files for collectingstoringanalyzing and reporting biological informationfor sample tracking and managing projectslaboratory workflow and dataall the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collectionmanagementanalysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific usenucleic acid sequencersimaging devices and analyzers
Classe 10
Clinical diagnostic instruments for medical usenucleic acid sequencersimaging devices and analyzers
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/01/2026
IUAF
USE AMENDMENT FILED
05/01/2026
EISU
TEAS STATEMENT OF USE RECEIVED
05/01/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/12/2025
EX5G
SOU EXTENSION 5 GRANTED
11/12/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/12/2025
EXT5
SOU EXTENSION 5 FILED
30/06/2025
EEXT
SOU TEAS EXTENSION RECEIVED
30/06/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX4G
SOU EXTENSION 4 GRANTED
26/12/2024
EXT4
SOU EXTENSION 4 FILED
26/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
26/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/06/2024
EX3G
SOU EXTENSION 3 GRANTED
25/06/2024
EXT3
SOU EXTENSION 3 FILED
25/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
25/06/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2023
EX2G
SOU EXTENSION 2 GRANTED
30/11/2023
EXT2
SOU EXTENSION 2 FILED
30/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
30/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2023
EX1G
SOU EXTENSION 1 GRANTED
06/06/2023
EXT1
SOU EXTENSION 1 FILED
06/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/11/2022
PUBO
PUBLISHED FOR OPPOSITION
08/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/03/2022
GNRT
NON-FINAL ACTION E-MAILED
09/03/2022
CNRT
NON-FINAL ACTION WRITTEN
09/03/2022
DOCK
ASSIGNED TO EXAMINER
28/02/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
31/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/08/2021
NWAP
NEW APPLICATION ENTERED
12/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace E ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.